For Mankind (MNKD +10.3%) no bad news is good news today, as the stock rips higher following an...

|By:, SA News Editor

For Mankind (MNKD +10.3%) no bad news is good news today, as the stock rips higher following an inline Q1 report late yesterday. Operating expenses rose by 9% Y/Y, primarily due to an increase in clinical trial related expenses.